Scott Worthington Appointed CFO of Biosign

TORONTO, Feb. 1 /CNW/ - Biosign Technologies Inc. (TSXV: BIO, "Biosign") announces the formal appointment of Scott Worthington as Chief Financial Officer.

Mr. Worthington has over 30 years of senior financial and executive management experience, including 9 years at Dell Computer Corporation, where he held numerous positions including Chief Financial Officer of the Canadian subsidiary. From 2008 to 2010, Mr. Worthington was Chief Financial Officer of NetShelter Technology Media, an advertising and media consulting firm, which provided services to over 160 leading independent technology websites, with over 124 million unique visitors per month. Prior to NetShelter, Mr. Worthington served as WaveRider Communication Inc.'s Vice President and Chief Financial Officer for eight years. Mr. Worthington has a Bachelor of Business Administration from York University and is a Chartered Accountant.

"Scott has shown a great level of understanding, commitment, and passion for the business since joining us as interim CFO in October 2010," stated Peter Tassiopoulos, CEO of Biosign. "His background and experience in technology operations is extremely relevant. He is a dynamic individual that will help us achieve our corporate goals."

About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit www.biosign.com


Forward-Looking Statements
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in, Biosign's filings with Canadian securities regulators (www.sedar.com).


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Biosign Technologies Inc.

For further information:

Peter Tassiopoulos    Alan S. Roemer, SVP
Biosign Technologies Inc.    The Trout Group LLC
Phone: (416) 218-9800 ext. 234    Phone: 646 378-2900
Email: ceo@biosign.com Email: aroemer@troutgroup.com

Organization Profile

Biosign Technologies Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890